Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

STOK Stock Forecast, Price Targets, Chart, Dividends & Analysis

Stoke Therapeutics Inc. logo

Stoke Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

11.68
 
USD
  
0.38
  
(3.36%)
Previous close: 11.3  Open: 10.81  Bid: 10.0  Ask: 12.15
52 week range    
4.09   
   17.58
Mkt Cap: 641 M  Avg Vol (90 Days): 541,126
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

44
MarketXLS Rank
60
Value
46
Technical
26
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

STOK Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-1.56-2.34-2.6-2.38
Basic EPS total-1.56-2.34-2.6-2.38
Basic weighted shares outstanding18 M33 M37 M39 M44 M
Depreciation-450000.0900000.01000000.02 M3 M
DepreciationAndAmortization-450000.0900000.01000000.02 M3 M
Diluted EPS total-1.8-1.56-2.34-2.6-2.38
Diluted normalized net income/share-2.6-2.38
Diluted weighted shares outstanding18 M33 M39 M44 M
GeneralAndAdministrativeExpense12 M21 M32 M39 M41 M
Gross operating profit12 M9 M
Income before tax-32 M-52 M-86 M-101 M-105 M
Interest income3 M700000.0120000.03 M10 M
MiscOtherSpecialCharges2000.0101000.0140000.0167000.0166000.0
Net income from total operations-32 M-52 M-86 M-101 M-105 M
NetIncomeCommonStockholders-32 M-52 M-86 M-101 M-105 M
NetIncomeContinuousOperations-32 M-52 M-86 M-101 M-105 M
NetNonOperatingInterestIncomeExpense3 M700000.0120000.03 M10 M
Normalized income-68 M-83 M
Operating income-36 M-53 M-86 M-104 M-115 M
Operating income before depreciation (EBITDA)-32 M-52 M-85 M-103 M-112 M
OperatingExpense-36 M53 M86 M117 M124 M
Other income net-2000.0-101000.0-140000.0167000.0166000.0
OtherGandA12 M21 M32 M39 M41 M
OtherOperatingExpenses-36 M53 M
RentAndLandingFees12 M
Research & development expense24 M32 M54 M78 M82 M
ResearchExpense24 M32 M54 M78 M82 M
SalariesAndWages-2 M
Selling Gen & administrative expense12 M21 M32 M39 M41 M
Total Income available for interest expense (EBIT)-32 M-53 M-86 M-104 M-115 M
Total common shares outstanding33 M37 M37 M44 M46 M
Total net income-32 M-52 M-86 M-101 M-105 M
Total ordinary shares53 M53 M53 M53 M53 M
Total revenues12 M9 M
TotalExpenses-36 M53 M86 M117 M124 M
TotalRevenue12 M9 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University